Prevalence and significance of pulmonary disease on lung ultrasonography in outpatients with SARS-CoV-2 infection.
Robert M FairchildAudra HoromanskiDiane A MarGabriela R TriantRong LuDi LuHaiwei Henry GuoMatthew C BakerPublished in: BMJ open respiratory research (2021)
We found a high prevalence of LUS findings in outpatients with SARS-CoV-2 infection. Given the pervasiveness of pulmonary disease across a broad spectrum of LUS severity scores and lack of adverse outcomes, our findings suggest that LUS may not be a useful as a risk stratification tool in SARS-CoV-2 in the general outpatient population.